ArticleFrontiers in endocrinology2026
Case Report: Continuous block-and-replace strategy with osilodrostat in a patient with cyclic Cushing's syndrome.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence on cyclic Cushing's syndrome (cCS) is limited. Due to its rarity and diagnostic challenges, some patients remain undiagnosed and experience life-threatening episodes of hyper- and hypocortisolemia. We present a case of a 68-year-old male with a 5-year history of recurrent hospitalizations due to infections, sepsis, and episodes of blood pressure and glycemic instabilities, who was admitted to the Endocrinology Department for evaluation of bilateral adrenal incidentalomas. Physical examination revealed cushingoid features, and biochemical tests confirmed ACTH-dependent CS, with dynamic tests suggesting ectopic origin. Retrospective review showed several peaks of hypercortisolemia separated by spontaneous remissions. These fluctuations correlated with severe infections, hypertension, and hyperglycemia, followed by hypotension and improved metabolic control. Medical therapy with steroidogenesis inhibitors in a block-and-replace regimen resulted in sustained biochemical and clinical stabilization. Imaging failed to identify the ACTH source; therefore inferior petrosal sinus sampling is planned to definitively establish the etiology of CS. This case illustrates the unpredictable nature of cCS and the considerable challenges it poses for both diagnosis and management, emphasizing the need for individualized therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.